Pages that link to "Q41315564"

The following pages link to Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies (Q41315564):

Displaying 46 items.

• NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo (Q24679444) (← links)
• In vivo indomethacin treatment causes microglial activation in adult mice (Q28376563) (← links)
• beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. (Q31840031) (← links)
• Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice (Q32134064) (← links)
• TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice (Q33343490) (← links)
• Heparin in inflammation: potential therapeutic applications beyond anticoagulation. (Q33637649) (← links)
• Recent developments in the drug treatment of Alzheimer's disease (Q33688768) (← links)
• Mild cognitive impairment: emerging therapeutics (Q34072149) (← links)
• Cyclooxygenase and Alzheimer's disease: implications for preventive initiatives to slow the progression of clinical dementia (Q34312617) (← links)
• Immunological aspects of microglia: relevance to Alzheimer's disease (Q34386107) (← links)
• Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease (Q34626110) (← links)
• Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention (Q34677583) (← links)
• Potential novel targets for Alzheimer pharmacotherapy: I. Secretases (Q34703558) (← links)
• The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? (Q35502548) (← links)
• PMC-12, a Prescription of Traditional Korean Medicine, Improves Amyloid β-Induced Cognitive Deficits through Modulation of Neuroinflammation. (Q35511034) (← links)
• Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans (Q35936632) (← links)
• Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke (Q35974043) (← links)
• Alcohol, wine and mental health: focus on dementia and stroke (Q35975416) (← links)
• Inflammatory processes and Alzheimer's disease (Q36106855) (← links)
• The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications (Q37029352) (← links)
• Interactions between APP secretases and inflammatory mediators (Q37195010) (← links)
• Latest Study on the Relationship between Pathological Process of Inflammatory Injury and the Syndrome of Spleen Deficiency and Fluid Retention in Alzheimer's Disease (Q38209663) (← links)
• The effect of OTK18 upregulation in U937 cells on neuronal survival (Q39879114) (← links)
• Molecular markers of amnestic mild cognitive impairment among Mexican Americans. (Q40457858) (← links)
• Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha (Q40777805) (← links)
• The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation (Q41706054) (← links)
• Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia. (Q43720394) (← links)
• The effect of IL4 33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease (Q43957525) (← links)
• Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease (Q43992276) (← links)
• Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system. (Q43999092) (← links)
• Protective effect of vitamin C against the ethanol mediated toxic effects on human brain glial cells (Q44617756) (← links)
• Triglyceride-rich lipoprotein lipolysis products increase blood-brain barrier transfer coefficient and induce astrocyte lipid droplets and cell stress (Q44646913) (← links)
• Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia (Q48271277) (← links)
• HLA-DR4 influences glial activity in Alzheimer's disease hippocampus (Q48310858) (← links)
• Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease (Q48373983) (← links)
• Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs (Q50912773) (← links)
• A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. (Q53228560) (← links)
• Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. (Q53232489) (← links)
• Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. (Q53306169) (← links)
• Interleukin-6 −174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: A meta-analysis (Q53320752) (← links)
• A review: inflammatory process in Alzheimer's disease, role of cytokines. (Q53328528) (← links)
• HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity (Q64115135) (← links)
• Estrogen blocks inducible nitric oxide synthase accumulation in LPS-activated microglia cells (Q73289899) (← links)
• Variability of natural killer (NK) cell immune function in normal aging and senile dementia: pathophysiological implications (Q73850318) (← links)
• Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations (Q73919929) (← links)
• Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases (Q78052078) (← links)